AKBA · Akebia Therapeutics, Inc. · Documents
$0.64
-0.04 (-5.37%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$177.65M
Shares
277.11M
Volume · Oct 20
4.14M
Avg daily vol (3M)
6.72M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-K | — | 2021-02-25 | 2020-12-31 | |
| 8-K | — | 2021-02-25 | — | |
| 8-K | — | 2021-02-18 | 2021-02-16 | |
| 8-K | — | 2021-02-17 | 2021-02-10 | |
| 8-K | — | 2021-01-28 | 2021-01-26 | |
| 8-K | — | 2021-01-12 | — | |
| 8-K | — | 2020-12-15 | 2020-12-10 | |
| 8-K | — | 2020-12-02 | 2020-11-30 | |
| 10-Q | — | 2020-11-05 | 2020-09-30 | |
| 8-K | — | 2020-11-05 | — | |
| 8-K | — | 2020-09-25 | 2020-09-24 | |
| 8-K | — | 2020-09-11 | 2020-09-04 | |
| 8-K | — | 2020-09-03 | — | |
| 8-K | — | 2020-08-10 | — | |
| 10-Q | — | 2020-08-10 | 2020-06-30 | |
| 8-K | — | 2020-06-18 | 2020-06-15 | |
| 8-K | — | 2020-06-09 | 2020-06-05 | |
| DEFA14A | — | 2020-05-21 | — | |
| 8-K | — | 2020-05-12 | 2020-05-11 | |
| 8-K | — | 2020-05-05 | — | |
| 10-Q | — | 2020-05-05 | 2020-03-31 | |
| DEF 14A | — | 2020-04-23 | 2020-06-05 | |
| DEFA14A | — | 2020-04-23 | — | |
| 8-K | — | 2020-04-20 | — | |
| PRE 14A | — | 2020-04-10 | 2020-06-04 | |
| 8-K | — | 2020-04-08 | 2020-04-02 | |
| 8-K | — | 2020-04-07 | 2020-04-03 | |
| 8-K | — | 2020-03-12 | — | |
| 10-K | — | 2020-03-12 | 2019-12-31 | |
| 8-K | — | 2020-03-10 | — | |
| 8-K | — | 2020-02-18 | 2020-02-14 |
Showing 151–181 of 181 filings
Key facts
CIK
1517022
CUSIP
00972D105
13F (30d)
17 filings
17 filers
Visit website
Investor relations